KITA (Chairman: Jin Sik Yoon) and the Abu Dhabi Chamber of Commerce & Industry (ADCCI) co-organised "Seoul - Abu Dhabi Business Matchmaking Forum" on Thursday, 17 September at KITA HQs in Seoul.
This forum was organised by taking ADCCI delegation's visit to Korea as an opportunity to offer information on establishing a business in Abu Dhabi for Korean businesses and providing networking opportunities with business representatives from Abu Dhabi. Approximately 90 people, including KITA Senior Executive Director Seok Min Jang, ADCCI Director General Ali Mohamed Al Marzooqi, business representatives and officials from relevant institutions from both Korea and Abu Dhabi attended the Forum.
In his opening remarks, KITA Senior Executive Director Seok Min Jang mentioned, "It is now time to deliver results as Korea - UAE CEPA, an institutional measure that supports a new chapter of bilateral cooperation, took effect in May this year." He added, "I hope new connections established today will translate into concrete results through striking new deals for exports and investments and write new success stories of bilateral economic cooperation."
In his welcome remarks, ADCCI Director General Ali Mohamed Al Marzooqi stresssed, "Korea is an important partner for cooperation armed with top-notch competitiveness in manufacturing and cutting-edge technology sectors, such as AI, military equipment, mobility, bioengineering and healthcare" and added, "As Abu Dhabi is a market opened for Korean companies in many business sectors, I hope today's opportunity will serve as a chance of boosting bilateral cooperation."
One notable partnership established today include a strategic partnership aimed at promoting the globalisation of Korean medicine. This partnership was signed during the opening ceremony between Jaseng Medical Academy and Emirates International Hospital Group (EIHG). Young-Suk Yoon, the Director of Jaseng Medical Academy and Leenus Patrick Obed, the CEO of EIHG highlighted that the two organisations will work together by making best use of this parnership to design detailed bilateral projects such as boosting success rates of clinical trials and optimising medical cost.